By InvitationNot Applicable

Improving Hypertension Management Through Preference List Defaults

United States12,150 participantsStarted 2026-04-13

Plain-language summary

This study aims to evaluate whether modifying the EPIC preference list to display combination blood pressure (BP) medications at the top and/or adding "(PREFERRED)" to the beginning of the medication listing increases prescribing of these medications. Combination BP medications are aligned with value-based care guidelines and may improve patient adherence and reduce pill burden. Currently, these medications may be under-prescribed in part due to their low visibility in the EPIC prescribing interface.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Order placed for a medication starting with any of the following: "amlodipine", "benazepril", "valsartan", "lisinopril", "hctz", "hydrochlorothiazide", "hydro", "losartan" * The order is placed at an in-person, virtual (telemed), telephone, or nurse encounter in a clinic included in the study * Patient is age 18+ Exclusion Criterion: \- Order was placed by a clinical leader who was aware of the study

What they're measuring

Prescribing of Combination Antihypertensive Medication (y/n)

Timeframe: Day of the appointment (1 day)

Trial details

NCT IDNCT07298694

SponsorGeisinger Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10

View on ClinicalTrials.gov More Hypertension trials